Zomedica Analyst Ratings
Zomedica Analyst Ratings
While ratings are subjective and will change, the latest Zomedica (ZOM) rating was a initiated with a price target of $0.00 to $6.00. The current price Zomedica (ZOM) is trading at is $0.19, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/06/2023 | 3031.52% | Dawson James | → $6 | Initiates Coverage On | → Buy |
| 11/16/2020 | 56.58% | HC Wainwright & Co. | $0.5 → $0.3 | Maintains | Buy |
| 06/17/2020 | 160.96% | HC Wainwright & Co. | $0.65 → $0.5 | Maintains | Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 01/06/2023 | 3031.52% | 道森·詹姆斯 | → 6 美元 | 啟動覆蓋範圍 | → 購買 |
| 11/16/2020 | 56.58% | HC 溫賴特 & 有限公司. | 0.5 美元 → 0.3 美元 | 維護 | 購買 |
| 2020 年 06 月 17 日 | 160.96% | HC 溫賴特 & 有限公司. | 六十五美元 → 0.5 美元 | 維護 | 購買 |
What is the target price for Zomedica (ZOM)?
佐美迪卡 (ZOM) 的目標價格是多少？
The latest price target for Zomedica (AMEX: ZOM) was reported by Dawson James on January 6, 2023. The analyst firm set a price target for $6.00 expecting ZOM to rise to within 12 months (a possible 3031.52% upside). 1 analyst firms have reported ratings in the last year.
道森詹姆斯於 2023 年 1 月 6 日報導了佐美迪卡（AMEX 代碼：ZOM）的最新目標價格。該分析師公司設定了 6.00 美元的價格目標，預計 ZOM 將在 12 個月內上升（可能是 3031.52％ 上漲）。1 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Zomedica (ZOM)?
佐美迪卡 (ZOM) 的最新分析師評級為何？
The latest analyst rating for Zomedica (AMEX: ZOM) was provided by Dawson James, and Zomedica initiated their buy rating.
佐美迪卡（AMEX：ZOM）的最新分析師評級由道森詹姆斯提供，佐美迪卡發起了他們的購買評級。
When is the next analyst rating going to be posted or updated for Zomedica (ZOM)?
Zomedica (ZOM) 的下一個分析師評級何時會公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zomedica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zomedica was filed on January 6, 2023 so you should expect the next rating to be made available sometime around January 6, 2024.
分析師在進行了廣泛的研究後到達股票評級，其中包括通過公共財務報表，與 Zomedica 的高管和客戶交談以及收聽盈利電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。佐美迪卡的最後一個評分於 2023 年 1 月 6 日提交，因此您應該期望下一個評分將在 2024 年 1 月 6 日左右的某個時候提供。
Is the Analyst Rating Zomedica (ZOM) correct?
分析師等級佐美迪卡 (ZOM) 是否正確？
While ratings are subjective and will change, the latest Zomedica (ZOM) rating was a initiated with a price target of $0.00 to $6.00. The current price Zomedica (ZOM) is trading at is $0.19, which is within the analyst's predicted range.
雖然評分是主觀的並且會發生變化，但最新的佐美迪卡（ZOM）評級是啟動的，目標價格為 0.00 美元至 6.00 美元。目前的價格佐美迪卡（ZOM）的交易價格為 0.19 美元，這是在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
